Cleared Traditional

K161883 - CompuFlo Epidural Computer Controlled Anesthesia System

K161883 is an FDA 510(k) clearance for CompuFlo Epidural Computer Controlled A..., manufactured by Milestone Scientific, Inc.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 333-day FDA review.

K161883 · Milestone Scientific, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2017
Decision
333d
Days
Class 2
Risk

K161883 is an FDA 510(k) clearance for the CompuFlo Epidural Computer Controlled Anesthesia System. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Milestone Scientific, Inc. (Livingston, US). The FDA issued a Cleared decision on June 9, 2017 after a review of 333 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Milestone Scientific, Inc. devices

FDA 510(k) Submission Details - K161883

510(k) Number K161883 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 11, 2016
Decision Date June 09, 2017
Days to Decision 333 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
204d slower than avg
Panel avg: 129d · This submission: 333d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 553
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K161883.
Luer-Jack Slip 3 ml, Luer-Jack Slip 5 ml, Luer-Jack Slip 20 ml, Luer-Jack Lock 10 ml
K171805 · Conceptomed AS · Sep 2017
Merit Syringe
K171362 · Merit Medical Systems, Inc. · Aug 2017
Graftgun Universal Graft Delivery System
K170675 · SurGenTec, LLC · Jul 2017
BD Ultra-Fine™ Insulin Syringe, BD Ultra-Fine™ II Insulin Syringe, BD Insulin Syringes with the BD Ultra-Fine™ needle and BD Insulin Syringes with Micro-Fine™ IV Needle
K170386 · Becton, Dickinson Company · Apr 2017
Freedom Syringe
K161812 · Procedure Products, Inc. · Mar 2017
Sterile Single-use Syringe with Needle
K163161 · Jiangxi Hongda Medical Equipment Group , Ltd. · Mar 2017